Detection and mapping of quantitative trait loci that determine responsiveness of mice to nitrous oxide antinociception

Neuroscience

Volumn 123, Issue 3, 2004, Pages 743-749

  Mueller, J L ^a   Ellenberger, E A ^a   Vaughn, L K ^b   Belknap, J K ^c   Quock, R M ^a,d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b MARQUETTE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Antinociception; Mice; Nitrous oxide; Quantitative trait loci

Indexed keywords

ACETIC ACID; GENOMIC DNA; NITROUS OXIDE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 2; CHROMOSOME 5; CHROMOSOME MAP; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; DRUG RESPONSE; FEMALE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; GENOME ANALYSIS; GENOTYPE; INBRED STRAIN; MALE; MARKER GENE; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROGENY; QUANTITATIVE TRAIT LOCUS; RESTRICTION MAPPING; SEX DIFFERENCE; SPLEEN;

EID: 0346729786     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.10.020     Document Type: Article

References (27)

1. Belknap J.K., Mitchell S.R., O'Toole L.A., Helms M.L., Crabbe J.C. Type I and type II error rates for quantitative trait loci (QTL) mapping studies using recombinant inbred mouse strains. Behav Genet. 26:1996;149-160.
2. Berkowitz B.A., Finck A.D., Hynes M.D., Ngai S.H. Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology. 51:1979;309-312.
3. Berkowitz B.A., Finck A.D., Ngai S.H. Nitrous oxide analgesia reversal by naloxone and development of tolerance . J Pharmacol Exp Ther. 203:1977;539-547.
4. Berkowitz B.A., Ngai S.H., Finck A.D. Nitrous oxide "analgesia: " resemblance to opiate action . Science. 194:1976;967-968.
5. Branda E.M., Ramza J.T., Cahill F.J., Tseng L.F., Quock R.M. Role of brain dynorphin in nitrous oxide antinociception in mice. Pharmacol Biochem Behav. 65:2000;217-222.
6. Cahill F.J., Ellenberger E.A., Mueller J.L., Tseng L.F., Quock R.M. Antagonism of nitrous oxide antinociception in mice by intrathecally administered opioid peptide antisera. J Biomed Sci. 7:2000;299-303.
7. Churchill G.A., Doerge R.W. Empirical threshold values for quantitative trait loci mapping. Genetics. 138:1994;963-971.
8. Crabbe J.C., Phillips T.J., Kosobud A., Belknap J.K. Estimation of genetic correlation interpretation of experiments using selectively bred and inbred animals . Alcohol Clin Exp Res. 14:1990;141-151.
9. Darvasi A., Soller M. Selective genotyping for determination of linkage between a marker locus and a quantitative trait locus. Theor Appl Genet. 85:1992;353-359.
10. Darvasi A., Soller M. A simple method to calculate resolving power and confidence interval of QTL map location. Behav Genet. 27:1997;125-132.
11. 2O. 1985;41-55 Elsevier, New York.
12. Fujinaga M., Maze M. Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol. 25:2002;167-189.
13. Hood H., Belknap J.K., Crabbe J.C., Buck K.J. Genome-wide search for epistasis in a complex trait pentobarbital withdrawal convulsions in mice . Behav Genet. 31:2001;93-100.
14. 2O stimulates NOS enzyme activity in C57BL/6 but not DBA/2 mice. Brain Res. 976:2003;262-263.
15. Ishikawa M., Quock R.M. Role of nitric oxide synthase isoforms in nitrous oxide antinociception in mice. J Pharmacol Exp Ther. 306:2003;484-489.
16. Jacob H.J., Brown D.M., Bunker R.K., Daly M.J., Dzau V.J., Goodman A., Koike G., Kren V., Kurtz T., Lernmark A., Levan G., Mao Y., Pettersson A., Pravenec M., Simon J.S., Szpirer C., Szpirer J., Trolliet M.R., Winer E.S., Lander E.S. A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet. 9:1995;63-69.
17. Lander E.S., Botstein D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics. 121:1989;185-198.
18. Lander E.S., Kruglyak L. Genetic dissection of complex traits guidelines for interpreting and reporting linkage results . Nat Genet. 11:1995;241-247.
19. McDonald C.E., Gagnon M.J., Ellenberger E.A., Hodges B.L., Ream J.K., Tousman S.A., Quock R.M. Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats. J Pharmacol Exp Ther. 269:1994;601-608.
20. Quock R.M., Best J.A., Chen D.C., Vaughn L.K., Portoghese P.S., Takemori A.E. Mediation of nitrous oxide analgesia in mice by spinal and supraspinal κ-opioid receptors. Eur J Pharmacol. 175:1990;97-100.
21. Quock R.M., Mueller J. Protection by U-50, 488H against β-chlornaltrexamine antagonism of nitrous oxide antinociception in mice. Brain Res. 549:1991;162-164.
22. 2O) antinociception. Brain Res. 614:1993;52-56.
23. Quock R.M., Mueller J.L., Vaughn L.K., Belknap J.K. Nitrous oxide antinociception in BXD recombinant inbred mouse strains and identification of quantitative trait loci. Brain Res. 725:1996;23-29.
24. Quock R.M., Vaughn L.K. Nitrous oxide mechanism of its analgesic action . Analgesia. 1:1995;151-159.
25. Sen S., Churchill G.A. A statistical framework for quantitative trait mapping. Genetics. 159:2001;371-387.
26. Sokal R.R., Rohlf F.J. Biometry. 1995;Freeman, San Francisco.
27. Sonnenschein R.R., Jamison R., Loveseth L.J., Cassels W.H., Ivy A.C. A study on the mechanism of nitrous oxide analgesia. J Appl Physiol. 1:1948;254-258.